TY  - GEN
AU  - Fernandez, Laura
AU  - Carrillo, Eugenia
AU  - Sánchez-Sampedro, Lucas
AU  - Sanchez Herrero, Carmen
AU  - Ibarra-Meneses, Ana Victoria
AU  - Jiménez, María Angeles
AU  - Almeida, Valter Dos Anjos
AU  - Esteban, Mariano
AU  - Moreno, Javier
PY  - 2018
DO  - 10.3389/fimmu.2018.00843
SN  - 1664-3224
UR  - http://hdl.handle.net/20.500.12105/8957
AB  - Leishmania-activated C-kinase antigen (LACK) is a highly conserved protein among Leishmania species and is considered a viable vaccine candidate for human leishmaniasis. In animal models, prime-boost vaccination with LACK-expressing plasmids plus...
LA  - eng
PB  - Frontiers Media
KW  - Leishmania-activated C-kinase antigen
KW  - Antigenicity
KW  - Cytokines
KW  - Hamster
KW  - Vaccine
KW  - Visceral leishmaniasis
KW  - Animals
KW  - Antigens, Protozoan
KW  - Cricetinae
KW  - Cytokines
KW  - Cytotoxicity Tests, Immunologic
KW  - DNA, Protozoan
KW  - Genetic Vectors
KW  - Humans
KW  - Interferon-gamma
KW  - Leishmania infantum
KW  - Leishmaniasis, Visceral
KW  - Leukocytes, Mononuclear
KW  - Male
KW  - Protozoan Proteins
KW  - Protozoan Vaccines
KW  - Th17 Cells
KW  - Vaccines, DNA
KW  - Vaccinia virus
KW  - Immunization, Secondary
KW  - Immunogenicity, Vaccine
TI  - Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters
TY  - research article
ER  -